Olmutinib (奥莫替尼)
药物名称Olmutinib (奥莫替尼)药物结构
![](http://pic.ikafan.com/imgp/L3Byb3h5L2h0dHBzL2ltYWdlMTA5LjM2MGRvYy5jbi9Eb3dubG9hZEltZy8yMDIxLzAzLzE4MTIvMjE3OTQyMzQ2XzFfMjAyMTAzMTgxMjIwMDMyNTU=.jpg)
商品名称待更新适应症非小细胞肺癌给药途径口服制剂靶点EGFR药物特点Olmutinib是一种新型的EGFR突变特效性酪氨酸激酶抑制剂、布鲁顿氏酪氨酸激酶抑制剂。原研公司韩美制药研发历史待更新上市时间2016国内上市时间未上市国内申报厂家无原研专利信息专利号到期日专利名称WO-20111625152031Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity全球销售预测暂无原研工艺路线待更新杂质信息待更新Olmutinib汤森路透Cortellis报告免费下载https://pan.baidu.com/s/1RV0zBrHNjbN7LLWPGryL0w学如逆水行舟,不进则退;心似平原走马,易放难收。
![](http://pic.ikafan.com/imgp/L3Byb3h5L2h0dHBzL2ltYWdlMTA5LjM2MGRvYy5jbi9Eb3dubG9hZEltZy8yMDIxLzAzLzE4MTIvMjE3OTQyMzQ2XzJfMjAyMTAzMTgxMjIwMDM2NzY=.jpg)
行舟Drug
赞 (0)